Reuters -- Swiss drugmaker Roche Holding AG is likely to review the compensation policy for its staff at U.S. biotech unit Genentech, Chief Executive Severin Schwan told the Financial Times.
Reuters -- Swiss drugmaker Roche Holding AG is likely to review the compensation policy for its staff at U.S. biotech unit Genentech, Chief Executive Severin Schwan told the Financial Times.
